{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:46:06Z","timestamp":1782960366067,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005902","name":"Institute for Clinical and Translational Research, University of Wisconsin, Madison","doi-asserted-by":"publisher","award":["1UM1TR004926-01"],"award-info":[{"award-number":["1UM1TR004926-01"]}],"id":[{"id":"10.13039\/100005902","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012304","name":"The Johns Hopkins University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jtha.2025.04.006","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T13:06:50Z","timestamp":1744895210000},"page":"2242-2254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Soluble P-selectin, but not circulating cell-free DNA, is a potential diagnostic biomarker in heparin-induced thrombocytopenia"],"prefix":"10.1016","volume":"23","author":[{"given":"Soha S.","family":"Ramadan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhananjay","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Dane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed L.","family":"Galgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Abadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Streiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5764-5454","authenticated-orcid":false,"given":"Ivo M.B.","family":"Francischetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.04.006_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/hematology.2023000503","article-title":"Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond","volume":"2023","author":"Greinacher","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2025.04.006_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/ATVBAHA.120.315445","article-title":"Heparin-induced thrombocytopenia: a focus on thrombosis","volume":"41","author":"Arepally","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.04.006_bib3","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.04.006_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MOH.0000000000000551","article-title":"Platelets as key players in inflammation and infection","volume":"27","author":"Nicolai","year":"2020","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jtha.2025.04.006_bib5","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1097\/01.CCM.0000126364.46191.12","article-title":"Protease-activated receptor signaling in the regulation of inflammation","volume":"32","author":"Ruf","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2025.04.006_bib6","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41467-019-09160-7","article-title":"Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia","volume":"10","author":"Perdomo","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2025.04.006_bib7","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1038\/ncomms9277","article-title":"Atomic description of the immune complex involved in heparin-induced thrombocytopenia","volume":"6","author":"Cai","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2025.04.006_bib8","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2010-03-276964","article-title":"Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia","volume":"116","author":"Rauova","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.006_bib9","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ajh.24759","article-title":"Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia","volume":"92","author":"Kuter","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2025.04.006_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nri.2017.21","article-title":"Mitochondrial DNA in innate immune responses and inflammatory pathology","volume":"17","author":"West","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtha.2025.04.006_bib11","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949799","article-title":"Mitochondrial DNA in inflammation and immunity","volume":"21","author":"Riley","year":"2020","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jtha.2025.04.006_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41420-019-0188-0","article-title":"Platelet factor 4-containing immune complexes induce platelet activation followed by calpain-dependent platelet death","volume":"5","author":"Nevzorova","year":"2019","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.jtha.2025.04.006_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12979-023-00342-y","article-title":"Associations between circulating cell-free mitochondrial DNA, inflammatory markers, and cognitive and physical outcomes in community dwelling older adults","volume":"20","author":"Nidadavolu","year":"2023","journal-title":"Immun Ageing"},{"key":"10.1016\/j.jtha.2025.04.006_bib14","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3233\/JAD-220301","article-title":"Circulating cell-free genomic DNA is associated with an increased risk of dementia and with change in cognitive and physical function","volume":"89","author":"Nidadavolu","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jtha.2025.04.006_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fimmu.2018.00190","article-title":"Immunothrombotic activity of damage-associated molecular patterns and extracellular vesicles in secondary organ failure induced by trauma and sterile insults","volume":"9","author":"Eppensteiner","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2025.04.006_bib16","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","article-title":"DAMPs and DAMP-sensing receptors in inflammation and diseases","volume":"57","author":"Ma","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.jtha.2025.04.006_bib17","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood.2020008195","article-title":"A prospective, blinded study of a PF4-dependent assay for HIT diagnosis","volume":"137","author":"Samuelson","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.006_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.3786","article-title":"Accuracy of diagnosing heparin-induced thrombocytopenia","volume":"7","author":"Larsen","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jtha.2025.04.006_bib19","article-title":"Elucidation of cellular contributions to heparin-induced thrombocytopenia using omic approaches","volume":"12","author":"Giles","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jtha.2025.04.006_bib20","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1177\/08971900221116185","article-title":"The impact of an antithrombotic stewardship program on heparin-induced thrombocytopenia management","volume":"36","author":"Lee","year":"2023","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.jtha.2025.04.006_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101069","article-title":"Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection","volume":"39","author":"Francischetti","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jtha.2025.04.006_bib22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/jha2.654","article-title":"SARS-CoV-2 infection results in upregulation of Plasminogen Activator Inhibitor-1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity","volume":"4","author":"Toomer","year":"2023","journal-title":"EJHaem"},{"key":"10.1016\/j.jtha.2025.04.006_bib23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.jtha.2025.04.006_bib24","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1055\/s-0038-1657669","article-title":"Plasma levels of soluble Fc gamma receptors II (sCD32) and III (sCD16) in patients with heparin-induced thrombocytopenia","volume":"78","author":"Saffroy","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.006_bib25","doi-asserted-by":"crossref","first-page":"7542","DOI":"10.1038\/s41467-023-43310-2","article-title":"Megakaryocyte- and erythroblast-specific cell-free DNA patterns in plasma and platelets reflect thrombopoiesis and erythropoiesis levels","volume":"14","author":"Moss","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2025.04.006_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCRESAHA.117.310795","article-title":"Circulating platelets as mediators of immunity, inflammation, and thrombosis","volume":"122","author":"Koupenova","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2025.04.006_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13148-020-00825-5","article-title":"Platelet mitochondrial DNA methylation predicts future cardiovascular outcome in adults with overweight and obesity","volume":"12","author":"Corsi","year":"2020","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.jtha.2025.04.006_bib28","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1021\/acs.jproteome.3c00761","article-title":"Plasma instead of serum avoids critical confounding of clinical metabolomics studies by platelets","volume":"23","author":"Hagn","year":"2024","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jtha.2025.04.006_bib29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.21037\/tlcr.2017.09.13","article-title":"Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparation","volume":"6","author":"Kong","year":"2017","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtha.2025.04.006_bib30","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1182\/bloodadvances.2024012782","article-title":"Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia","volume":"8","author":"Nilius","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.04.006_bib31","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood.V83.6.1535.1535","article-title":"Plasma P-selectin is increased in thrombotic consumptive platelet disorders","volume":"83","author":"Chong","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.006_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/107602960000600204","article-title":"Soluble P-selectin in human plasma: effect of anticoagulant matrix and its levels in patients with cardiovascular disorders","volume":"6","author":"Amin","year":"2000","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.04.006_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99445","article-title":"Neutrophil accumulation and NET release contribute to thrombosis in HIT","volume":"3","author":"Gollomp","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtha.2025.04.006_bib34","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1160\/TH16-02-0162","article-title":"Role of monocytes and endothelial cells in heparin-induced thrombocytopenia","volume":"116","author":"Madeeva","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.006_bib35","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1172\/JCI90958","article-title":"Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia","volume":"127","author":"Hayes","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2025.04.006_bib36","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1021\/jacs.4c05090","article-title":"Total synthesis of a PSGL-1 glycopeptide analogue for targeted inhibition of P-selectin","volume":"146","author":"Dhakal","year":"2024","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.jtha.2025.04.006_bib37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jacc.2022.04.034","article-title":"Association of thromboxane generation with survival in aspirin users and nonusers","volume":"80","author":"Rade","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.04.006_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2018-02-769026","article-title":"Activated protein C, protease activated receptor 1, and neuroprotection","volume":"132","author":"Griffin","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.04.006_bib39","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1111\/jth.15873","article-title":"Mechanisms of ADAMTS13 regulation","volume":"20","author":"DeYoung","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.006_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s44161-023-00224-y","article-title":"The angiopoietin receptor Tie2 is atheroprotective in arterial endothelium","volume":"2","author":"Anisimov","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.jtha.2025.04.006_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.171054","article-title":"Platelet factor 4 limits neutrophil extracellular trap- and cell-free DNA-induced thrombogenicity and endothelial injury","volume":"8","author":"Ngo","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtha.2025.04.006_bib42","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.04.006_bib43","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/jth.14759","article-title":"Cytokine and chemokine regulation of venous thromboembolism","volume":"18","author":"Najem","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.006_bib44","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1111\/jth.15856","article-title":"Minimal role for the alternative pathway in complement activation by HIT immune complexes","volume":"20","author":"Barnes","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.04.006_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/jnnp-2016-314817","article-title":"Anti-inflammatory approaches to ischaemic stroke prevention","volume":"89","author":"Kelly","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625002569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625002569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:13:25Z","timestamp":1782958405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625002569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1538783625002569"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.04.006","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble P-selectin, but not circulating cell-free DNA, is a potential diagnostic biomarker in heparin-induced thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}